In a report released yesterday, Srikripa Devarakonda from Truist Financial maintained a Buy rating on Pfizer (PFE – Research Report), with a ...

The board of Pfizer Inc. ( NYSE:PFE ) has announced that it will be paying its dividend of $0.43 on the 7th of ...

The board of Pfizer Inc. ( NYSE:PFE ) has announced that it will be paying its dividend of $0.43 on the 7th of ...

We have been writing about Viatris since 2021, and it is now on our radar as a potential stock to buy. Read the full analysis ...

Here are four large-cap value stocks that growth and income investors may want to consider now. History suggests they will ...

These five high-yield dividend stocks have the potential to deliver positive total returns and dependable passive income.

Regeneron Pharmaceuticals is a strong investment with robust growth potential, fueled by FDA approvals and resilient market ...

Below is Validea's guru fundamental report for PFIZER INC (PFE). Of the 22 guru strategies we follow, PFE rates highest using our Shareholder Yield Investor model based on the published strategy ...

Analysts expect companies in the artificial intelligence market to spearhead tech sector funding in 2025, driven by increased expectations of exponential growth in the next few years as uses for ...

In a report released yesterday, Srikripa Devarakonda from Truist Financial maintained a Buy rating on Bristol-Myers Squibb (BMY – Research ...